Return to Previous Page
Details
The cyclic RGD peptide cilengitide is a potential cancer drug. Cilengitide is under investigation for the treatment of glioblastoma, where it may act by inhibiting angiogenesis, and influencing tumor invasion and proliferation.
Catalog Number
H-8174
One Letter Code
c(RGDf(Me)V)
Synonyms
EMD 121974
Molecular Formula
C₂₇H₄₀N₈O₇
Relative Molecular Mass
588.66
CAS Registry Number
[188968-51-6] net
Source
Synthetic
Storage Conditions
-20 ± 5 °C
Links / Documents:
Brochures:
